Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 12, 2022 09:16 ET | Source: IMAC Holdings, Inc.

IMAC Holdings, Inc. Announces $3.9 Million Registered Direct and Private Placement

BRENTWOOD, Tenn., Aug. 12, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
April 07, 2022 08:47 ET | Source: IMAC Holdings, Inc.

IMAC Holdings Completes Walmart Pilot Program, Affirms Commitment to Growth

The Company plans to add 20 locations in the next 12 months BRENTWOOD, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces the...
February 16, 2022 09:30 ET | Source: IMAC Holdings, Inc.

IMAC Holdings, Inc. Announces Completion of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

BRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for...
October 04, 2021 09:30 ET | Source: IMAC Holdings, Inc.

IMAC Holdings Expands into Louisiana with Baton Rouge Orthopedic Business

Allen Johnston, M.D. Joins IMAC as a Medical Director, Expanding Company’s Footprint, Expertise in Sports Medicine BRENTWOOD, Tenn, Oct. 04, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings,...
July 13, 2021 09:00 ET | Source: IMAC Holdings, Inc.

IMAC Holdings, Inc. Announces Initiation of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

BRENTWOOD, Tenn, July 13, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has initiated the second cohort of its Phase 1 clinical trial for...
January 07, 2021 08:00 ET | Source: IMAC Holdings, Inc.

IMAC Holdings Appoints Sheri Gardzina as Secretary, Chief Financial Officer

BRENTWOOD, Tenn., Jan. 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
December 30, 2020 09:00 ET | Source: IMAC Holdings, Inc.

IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’s Disease

BRENTWOOD, Tenn., Dec. 30, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
November 30, 2020 16:05 ET | Source: IMAC Holdings, Inc.

IMAC Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement

BRENTWOOD, Tenn, Nov. 30, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
November 13, 2020 08:00 ET | Source: IMAC Holdings, Inc.

IMAC Holdings, Inc. To Participate in the Virtual Fall Investor Summit on November 16-18, 2020

BRENTWOOD, Tenn, Nov. 13, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...